Skip to content
Screener

PP&E (Net) at other companies

Gilead Sciences logo
Gilead SciencesGILD
$5.83B+6.9%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$1.07M+131%
LQD
Liquidia CorporationLQDA
$20.84M+146%
ALN
Alnylam PharmaceuticalsALNY
$554.14M+10.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.94M-26.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$374.82M-2.6%

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.45B+144%
Enterprise value$6.2B+151%
P/S10.4×+4.3×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045
Line itemJune 30,2026December 31,2025
Total current assets636,310549,684
Restricted cash1,7341,482
Long-term investments123,0308,105
Property and equipment, net2,2511,862
Operating lease right-of-use assets12,0248,741
Intangible assets, net247,388260,921
Other assets22,24412,018
Total assets$1,044,981$842,813

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirum Pharmaceuticals, Inc.'s PP&E (net)?
Mirum Pharmaceuticals, Inc. (MIRM) reported PP&E (net) of $2.25M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
Mirum Pharmaceuticals, Inc.'s PP&E (net) increased by 91.2% year-over-year, from $1.18M to $2.25M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s PP&E (net) has grown at a 7.6% compound annual growth rate (CAGR), from $1.29M to $1.86M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Mirum Pharmaceuticals, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude